Explore advanced Lung Cancer Treatment and Care, including surgery, targeted therapy, rehabilitation, and personalized treatment plans at LIV Hospital.
Send us all your questions or requests, and our expert team will assist you.
When it comes to lung cancer, having clear treatment details is essential for making informed decisions about care. This page provides comprehensive treatment details tailored to international patients who are considering options at Liv Hospital in Istanbul. Lung cancer remains one of the leading causes of cancer‑related death worldwide, with an estimated 2.2 million new cases diagnosed each year. Understanding the full spectrum of available therapies—from surgery to cutting‑edge immunotherapy—helps patients and families navigate the complex journey ahead.
Our overview covers the latest evidence‑based approaches, explains how each modality works, and outlines what you can expect during each phase of treatment. Whether you are newly diagnosed, seeking a second opinion, or planning a follow‑up, the treatment details presented here are designed to support you in coordinating care with confidence.
Liv Hospital’s multidisciplinary team combines expertise in oncology, thoracic surgery, radiology, and supportive care, ensuring that every patient receives a personalized plan that aligns with their clinical stage, genetic profile, and personal preferences.
Accurate staging is the cornerstone of effective lung cancer management. Staging determines the extent of disease spread and directly influences the selection of therapeutic options. The most widely used system is the TNM classification, which evaluates Tumor size (T), lymph Node involvement (N), and the presence of Metastasis (M). Early‑stage disease (Stage I‑II) is often confined to the lung and may be amenable to curative surgery, while advanced stages (Stage III‑IV) typically require multimodal approaches.
Staging also incorporates molecular profiling, which identifies actionable mutations (e.g., EGFR, ALK, ROS1) that guide targeted therapy. Understanding these details enables clinicians to match the most appropriate treatment to each patient’s disease biology.
At Liv Hospital, staging is performed using high‑resolution CT, PET‑CT, MRI, and, when indicated, invasive mediastinal sampling. The resulting treatment details are then discussed in a multidisciplinary tumor board, ensuring that every perspective—from surgery to medical oncology—is considered before a final plan is presented.
Surgery remains the gold standard for curative intent in patients with Stage I or II non‑small cell lung cancer (NSCLC) when the tumor is resectable and the patient has adequate pulmonary reserve. The primary goal is to remove the tumor with clear margins while preserving as much healthy lung tissue as possible.
All surgical candidates undergo pre‑operative pulmonary function testing and cardiopulmonary assessment to ensure safety. Post‑operative care includes pain management, respiratory physiotherapy, and early mobilization, which are integral parts of the overall treatment details.
When surgery is not feasible due to medical comorbidities, alternative curative options such as stereotactic body radiotherapy (SBRT) are considered, and these alternatives are discussed in the treatment details during the multidisciplinary review.
Radiation therapy plays a pivotal role across all stages of lung cancer, either as a definitive treatment, a neoadjuvant (pre‑surgical) measure, or as palliative care to relieve symptoms. Advanced technologies allow precise delivery of high‑dose radiation while sparing surrounding healthy tissue.
Typical treatment schedules vary: SBRT may be delivered in 3‑5 sessions, whereas conventional fractionated radiotherapy extends over 5‑7 weeks. Side‑effects such as esophagitis, pneumonitis, or fatigue are managed proactively with supportive medications and close monitoring.
Liv Hospital’s radiation oncology department utilizes image‑guided techniques and respiratory gating to synchronize beam delivery with the patient’s breathing cycle, enhancing accuracy and reducing toxicity. These technical details are incorporated into the overall treatment plan presented to each patient.
Systemic therapy addresses cancer cells that have spread beyond the primary lung tumor. The choice among chemotherapy, targeted agents, and immunotherapy depends on tumor histology, molecular profile, and prior treatments.
Combination regimens, such as chemo‑immunotherapy, have become standard for many patients with metastatic disease, offering improved overall survival compared with chemotherapy alone. Ongoing clinical trials at Liv Hospital provide access to novel agents and emerging biomarkers, further expanding the treatment details available to patients.
Monitoring during systemic therapy includes regular imaging, blood work, and assessment of toxicity. Dose adjustments or treatment interruptions are made based on tolerance, ensuring that patients receive the maximum therapeutic benefit while maintaining quality of life.
Every lung cancer case is unique, and the most effective treatment details arise from a collaborative, patient‑centered approach. At Liv Hospital, a multidisciplinary tumor board convenes weekly, bringing together thoracic surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, and supportive‑care specialists.
This structured workflow ensures that the treatment details presented to the patient are evidence‑based, feasible, and aligned with their personal goals. The inclusion of international patient coordinators further streamlines logistics, from visa assistance to accommodation, making the entire process transparent and stress‑free.
Undergoing lung cancer treatment far from home can be daunting. Liv Hospital offers a suite of support services designed to address logistical, emotional, and cultural needs, ensuring that patients can focus on healing.
All support services are coordinated by a dedicated International Patient Services team, which tracks each step of the patient journey to ensure seamless execution of the treatment details outlined by the clinical team.
Liv Hospital is a JCI‑accredited, internationally recognized cancer center in Istanbul. Our multidisciplinary expertise, state‑of‑the‑art technology, and dedicated international patient program combine to deliver high‑quality, personalized lung cancer care. We prioritize safety, transparency, and compassionate service, ensuring that every patient receives the most appropriate treatment details in a supportive environment.
Ready to discuss your lung cancer treatment options with world‑class specialists? Contact Liv Hospital today to schedule a confidential consultation and let our international patient team guide you every step of the way.
Send us all your questions or requests, and our expert team will assist you.
Patients at Liv Hospital can receive curative surgery such as VATS, RATS or open thoracotomy for early‑stage disease. Radiation options include SBRT, IMRT, proton therapy and concurrent chemoradiation for locally advanced tumors. Systemic treatments cover standard platinum‑based chemotherapy, targeted agents for EGFR, ALK, ROS1 and other driver mutations, and PD‑1/PD‑L1 immunotherapy either alone or combined with chemotherapy. All modalities are discussed in a multidisciplinary tumor board to create a personalized plan.
The TNM classification evaluates the primary tumor (T), regional lymph nodes (N) and distant metastasis (M). Early stages (I‑II) often qualify for surgery, while stage III may need combined chemoradiation and stage IV typically requires systemic therapy. Molecular profiling is added to identify actionable mutations, which can shift treatment toward targeted drugs. Accurate staging at Liv Hospital is performed with high‑resolution CT, PET‑CT, MRI and mediastinal sampling, ensuring the chosen therapy matches disease extent.
Video‑Assisted Thoracoscopic Surgery (VATS) is minimally invasive and suited for small peripheral tumors, offering a short hospital stay (3‑5 days) and quick return to activity. Robotic‑Assisted Thoracic Surgery (RATS) allows precise resection of more complex or central lesions with similar recovery times. Open thoracotomy is reserved for large or centrally located tumors requiring extensive lymph node dissection, with a longer hospital stay (7‑10 days) and recovery period (6‑8 weeks). Pre‑operative pulmonary function tests ensure patient safety.
Stereotactic Body Radiotherapy (SBRT) delivers high‑dose radiation in 3‑5 sessions for early‑stage tumors unsuitable for surgery. Intensity‑Modulated Radiation Therapy (IMRT) shapes the dose to irregular tumor volumes, ideal for locally advanced disease. Proton therapy uses charged particles to spare surrounding tissue, beneficial for tumors near critical structures. For stage III disease, concurrent chemoradiation combines chemotherapy with radiation to improve local control. Liv Hospital employs image‑guided and respiratory‑gated techniques to enhance precision and reduce toxicity.
International patients receive a full support package that includes medical coordination (appointment scheduling, record translation, liaison with referring physicians), travel and visa assistance, airport transfers, and discounted nearby accommodation. 24/7 interpreter services ensure clear communication during consultations and procedures. On‑site counseling, support groups and wellness programs address emotional needs, while a patient coordinator tracks the entire journey to keep the clinical plan transparent and stress‑free.
Your Comparison List (you must select at least 2 packages)
